Department of Psychiatry, University Medical Center Groningen
Groningen, 9700RB, Netherlands
NCT Number: NCT01048294
One of the most frequently investigated hypothesis of the pathophysiology underlying Seasonal Affective Disorder(SAD) or so called winterdepression is a disturbance of circadian rhythms. Since the circadian system is especially sensitive for the blue portion of the light spectrum, a new light therapy device with more blue light (blue enriched polychromatic light) was tested for its efficacy to treat SAD. In chronobiological terms this light is hypothesized to be more potent in inducing non-visual effects. In the present study fluorescent tubes that emit a high portion of short wavelength light on top of the normal wavelengths are tested for its superiority in treating SAD. This blue-enriched light (colour temperature 17000 ºK) is compared to standard light treatment (5000 º K) in SAD patients., The investigators hypothesise that blue- enriched light improve the therapeutic effects of light treatment leading to a higher response or the same response in a shorter time schedule compared to standard light treatment.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Groningen, 9700RB, Netherlands
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
9000 lux, 30 minutes in the morning
Other names: Philips energy light HF 3308; 2 lamps PLL36W color 5000K
9000 lux 20 minutes in the morning
Other names: Philips energy light HF 3308; 2 lamps PLL36W color 17000K
Time frame: days 1, 8, 15, 22
Time frame: once daily during 22 days
University Medical Center Groningen
Other
Gerandomiseerde en Gecontroleerde Studie Naar de Effecten Van Lichttoediening Met Een Hogere Kleurtemperatuur in Vergelijking Met de Standaard Lichttherapie in de Behandeling Van Winterdepressie
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03691792
Depressive Disorder, Mental Disorders
Burlington, Vermont, United States
View Trial DetailsNCT03313674
Depressive Disorder, Depressive Disorder, Major
Toronto, Ontario, Canada
View Trial DetailsNCT04251000
Depressive Disorder, Mental Disorders
New York, United States
View Trial DetailsNCT03403959
Depressive Disorder, Eye Diseases
Copenhagen Ø, Denmark
View Trial Details